Retatrutide Study Data and Research Context Retatrutide has attracted significant scientific interest because clinical research has reported substantial body-weight changes in controlled trial settings
Its important to note that its generally not recommended for women to take GLP-1s or other weight loss medications while looking to get pregnant, are currently pregnant, or are breastfeeding
The drug is known as a triple-agonist, meaning it targets three different receptors in the brain and throughout the body
Who should not take Lamictal
Specialist consultation included
Koppelman, S., Cera, M., Termine, M., Impoco, J., & Nick Gibbons